• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print

Corporate Spotlight

Race Oncology Ltd (RAC) is a specialty pharmaceutical company. Its business model is to pursue later stage drug assets, principally in the cancer field. Its important asset is a chemotherapy drug, called Bisantrene. Race Oncology is rediscovering Bisantrene.
View the full Corporate Spotlight arrow Created with Sketch.

director sees

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
RAC
2019 SP
14/03/19 56 16K
14/03/19 Last post  Lgalp65 Comments Created with Sketch.  56  Views Created with Sketch.  16K 
RAC 13/03/19 1 535
13/03/19 Last post  mcexplorer Comments Created with Sketch.  1  Views Created with Sketch.  535 
RAC 27/02/19 1 437
27/02/19 Last post  mcexplorer Comments Created with Sketch.  1  Views Created with Sketch.  437 
RAC
RAC (ASX) Corporate Spotlight Updates
25/02/19 2 559
25/02/19 Last post  Corporate Spotlight Comments Created with Sketch.  2  Views Created with Sketch.  559 
RAC 25/02/19 4 1.4K
25/02/19 Last post  EWexplorer Comments Created with Sketch.  4  Views Created with Sketch.  1.4K 
RAC 14/02/19 0 263
14/02/19 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  263 
RAC 12/02/19 1 558
12/02/19 Last post  mcexplorer Comments Created with Sketch.  1  Views Created with Sketch.  558 
RAC 12/02/19 1 503
12/02/19 Last post  mcexplorer Comments Created with Sketch.  1  Views Created with Sketch.  503 
RAC 12/02/19 0 229
12/02/19 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  229 
RAC 12/02/19 0 194
12/02/19 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  194 
RAC 08/02/19 3 960
08/02/19 Last post  EddyG Comments Created with Sketch.  3  Views Created with Sketch.  960 
RAC 31/01/19 2 3.0K
31/01/19 Last post  Infidel75 Comments Created with Sketch.  2  Views Created with Sketch.  3.0K 
RAC 23/01/19 13 3.0K
23/01/19 Last post  mcexplorer Comments Created with Sketch.  13  Views Created with Sketch.  3.0K 
RAC 22/01/19 0 265
22/01/19 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  265 
RAC
5 Million Shares bought by Insider
15/01/19 21 7.0K
15/01/19 Last post  mcexplorer Comments Created with Sketch.  21  Views Created with Sketch.  7.0K 
RAC
Mcap $6.7 M / Big EFFECTIVE Cancer Drug in P3 (MKT Size ~$500M+) =20+BAGGER
15/01/19 28 5.9K
15/01/19 Last post  Blockbuster Comments Created with Sketch.  28  Views Created with Sketch.  5.9K 

See All Discussions arrow Created with Sketch.

Corporate Spotlight

Timeline

Appendix 3B
13 Mar 19:04
 
Appendix 4D & Half-Year Financial Statements
27 Feb 16:19
 
Principal Investigator appointed for Bisantrene
25 Feb 09:10
 
Appendix 3Y-Dr William Garner
14 Feb 16:59
 
Change in substantial holding
12 Feb 18:01
 
Change of Director's Interest Notice-Mr Chris Ntoumenopoulos
12 Feb 17:55
 
View More arrow Created with Sketch.
(20min delay)
Last
7.5¢
Change
0.000(0.00%)
Mkt cap ! $6.804M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
2 105458 7.5¢
 

Sellers (Offers)

Price($) Vol. No.
7.7¢ 100000 1
View Market Depth
Last update - 16.12pm 20/03/2019 (20 minute delay) ?
(live)
Last
7.6¢
  Change
0.000 ( 1.33 %)
Open High Low Volume
7.6¢ 7.6¢ 7.6¢ 13000
Last updated 12.08pm 20/03/2019 (live) ?
RAC (ASX) Chart
GET SUPPORT arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.